S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Investors Face September Deadline in PROCEPT BioRobotics Securities Suit

Investors who lost more than $100,000 in PROCEPT BioRobotics stock between February 2024 and February 2026 have until September 22 to file as lead plaintiffs. The class action lawsuit, pending in the Northern District of California, alleges the medical device company misled shareholders regarding its inventory levels and sales figures.

Investors Face September Deadline in PROCEPT BioRobotics Securities Suit
Photo: Bio & News

The litigation, filed as Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation, claims executives failed to disclose material information regarding the company's U.S. handpiece sales. According to the complaint, the firm allegedly concealed that sales had consistently outpaced actual procedures since early 2023, leading to an excess of 10,000 units in field inventory.

Plaintiffs contend this inventory imbalance created a false picture of the company's operational health, inevitably causing a sharp decline in unit sales and forcing a miss on annual revenue targets. Shareholders seeking legal options or case evaluations can contact Kahn Swick & Foti, LLC or visit the ClaimsFiler portal to review their eligibility for the ongoing securities action.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!